Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

North China Pharmaceutical Group Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

North China Pharmaceutical Group Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

North China Pharmaceutical Group Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

North China Pharmaceutical Group Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes formulation products, nutrition and health products, raw materials, and veterinary drugs. The company offers sirolimus capsules, clindamycin phosphate injection, mezlocillin sodium for injection, ampicillin sodium for injection, amoxicillin sulbactam pills, amoxicillin dispersible tablets, cyclosporin soft capsule mecobalamin tablets and rocuronium bromide injection. Its nutrition and health products comprise chewable tablets, anyixin tablets, isomaric syrup, xin yan capsule and soft capsule. NCPC offers products in dosage forms of capsules, granules, injections, freeze-dried powder for injection, immunologic and biologic agent, nutrition supplement, tablets, veterinary and biocides products, powder for injection, antineoplastic agents, oral suspension and other formulations. The company markets its products across China. NCPC is headquartered in Shijiazhuang, China.

North China Pharmaceutical Group Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deal Details 9

Equity Offering 9

North China Pharma Receives Approval From China Securities Regulatory Commission For Private Placement Of Shares For USD 183.4 Million 9

North China Pharma Completes Private Placement Of Shares For USD 471 Million 10

Debt Offering 11

North China Pharma to Raise USD44 Million in Private Placement of Bonds Due 2021 11

North China Pharma to Raise up to USD74 Million in Private Placement of Bonds Due 2021 12

North China Pharma Raises USD147 Million in Public Offering of 5.3% Bonds Due 2018 13

North China Pharmaceutical Plans to Raise USD108.2 Million in Public Offering of Bonds Due 2021 14

North China Pharma Announces Public Offering Of Notes For USD 73 Million 15

Acquisition 16

NCPC To Sell North China Pharma Huasheng For USD 12 Million 16

NCPC To Sell 39% Stake In Shenzhen Medicine Company For USD 3 Million 17

NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For USD 14 Million 18

North China Pharma To Acquire Remaining 50% Stake In Pharmaceutical Company For USD 14.2 Million 19

North China Pharmaceutical Group Corp-Key Competitors 20

North China Pharmaceutical Group Corp-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

List of Tables

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Key Facts 2

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

North China Pharmaceutical Group Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

North China Pharma Receives Approval From China Securities Regulatory Commission For Private Placement Of Shares For USD 183.4 Million 9

North China Pharma Completes Private Placement Of Shares For USD 471 Million 10

North China Pharma to Raise USD44 Million in Private Placement of Bonds Due 2021 11

North China Pharma to Raise up to USD74 Million in Private Placement of Bonds Due 2021 12

North China Pharma Raises USD147 Million in Public Offering of 5.3% Bonds Due 2018 13

North China Pharmaceutical Plans to Raise USD108.2 Million in Public Offering of Bonds Due 2021 14

North China Pharma Announces Public Offering Of Notes For USD 73 Million 15

NCPC To Sell North China Pharma Huasheng For USD 12 Million 16

NCPC To Sell 39% Stake In Shenzhen Medicine Company For USD 3 Million 17

NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For USD 14 Million 18

North China Pharma To Acquire Remaining 50% Stake In Pharmaceutical Company For USD 14.2 Million 19

North China Pharmaceutical Group Corp, Key Competitors 20

North China Pharmaceutical Group Corp, Subsidiaries 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

North China Pharmaceutical Group Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person